Superior EFS and OS in Patients with Nonmetastatic Osteosarcoma and Unfavourable Prognosis when Adjuvant Mifamurtide is Combined with High-Dose Ifosfamide By Ogkologos - August 28, 2025 306 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ISG/OS-2 and GEIS-33 studies Source RELATED ARTICLESMORE FROM AUTHOR ESMO contributes to discussions on the future of cancer care at EU Cancer Mission event Multicancer early detection test detects tumour-derived cfDNA and demonstrates robust performance characteristics with a favourable safety profile Anito-cel, a d-Domain BCMA CAR T-Cell, Induces Rapid, Deep, and Durable Responses in Patients with Heavily Pretreated Relapsed or Refractory Multiple Myeloma MOST POPULAR 如果您剛確診為肺癌患者，請來看看專家的回答 April 22, 2021 EMA Recommends Extension of Therapeutic Indications for Brentuximab Vedotin June 12, 2025 ¿Vivir cerca de líneas eléctricas aumenta mi riesgo de desarrollar cáncer? February 23, 2023 Geriatric Assessment Intervention Reduces Patient-Reported Symptomatic Toxicities in Older Patients with... November 17, 2022 Load more HOT NEWS Study Reinforces Treatment Idea for Cancer with Microsatellite Instability Bra Straps with Disappearing Message Remind Women to Check Their Breasts... Sing Anyway Trial Highlights Complexities of Targeted Therapy for Pancreatic Cancer
